Pharmaceutical industry calls for structural reforms as Dublin ranked slowest in bloc for trial start-up times, and 14th out of 27 for per capita clinical trial activity in 2025

Rare disease wait times rise to 801 days despite new framework agreements and record investment

Pharmaceutical industry calls for structural reforms as Dublin ranked slowest in bloc for trial start-up times, and 14th out of 27 for per capita clinical trial activity in 2025